Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI

Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing in Spinal Cord Injured People

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This clinical trial will examine the efficacy of continuous positive airway pressure (CPAP) therapy in improving psychosocial, neurocognitive and behavioral consequences of moderate-to-severe sleep-related breathing disorders (SRBDs) in people living with spinal cord injury (SCI).

Who May Be Eligible (Plain English)

Who May Qualify: - English-speaking adults 18 years of age or older - Have traumatic cervical/thoracic (injury level at C5 to T10), severe or moderate (AIS A, B, or C) SCI who were not diagnosed with a sleep disorder prior to the injury. - At least 2 months after injury - Clinical warning symptoms and/or signs for SRBDs Who Should NOT Join This Trial: - Patients with a non-traumatic spinal cord disease at risk for neurologic progression - Concomitant diseases of the central nervous system - Preinjury chronic pain - Psychiatric disorders that may prevent the participant to be compliant to the study protocol requirements - Neuromuscular diseases - Current substance misuse - History of primary hypersomnia - Hypothyroidism - Moderate or severe iron deficiency anemia - Active infection - Kidney failure - Epilepsy - Chronic fatigue syndrome - Vitamin B12 deficiency Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * English-speaking adults 18 years of age or older * Have traumatic cervical/thoracic (injury level at C5 to T10), severe or moderate (AIS A, B, or C) SCI who were not diagnosed with a sleep disorder prior to the injury. * At least 2 months after injury * Clinical warning symptoms and/or signs for SRBDs Exclusion Criteria: * Patients with a non-traumatic spinal cord disease at risk for neurologic progression * Concomitant diseases of the central nervous system * Preinjury chronic pain * Psychiatric disorders that may prevent the participant to be compliant to the study protocol requirements * Neuromuscular diseases * Current substance misuse * History of primary hypersomnia * Hypothyroidism * Moderate or severe iron deficiency anemia * Active infection * Kidney failure * Epilepsy * Chronic fatigue syndrome * Vitamin B12 deficiency

Treatments Being Tested

OTHER

Continuous positive airway pressure (CPAP) therapy

The participants will undergo CPAP therapy for 4 consecutive months in the management of moderate-to-severe SRBDs

Locations (1)

Lyndhurst Centre, KITE - TRI UHN
Toronto, Ontario, Canada